The 404 patients were randomly assigned to the three groups, but 30 patients were excluded from the study for not following the dose-reduction rules. Intention-to-treat analyses were performed with the 125, 120, and 129 patients in the 4-week, 26-week, and no-dose-reduction groups, respectively. A flow chart of the study is displayed in Figure 1